NCT00555061 - Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions

Skin Infections, Bacterial

Interventions

DRUG

Retapamulin Ointment, 1%

1% Ointment

Trial Locations (25)

112

GSK Investigational Site, Taipei

1501

GSK Investigational Site, Benoni

2113

GSK Investigational Site, Newtown

6720

GSK Investigational Site, México

35401

GSK Investigational Site, Tuscaloosa

40699

GSK Investigational Site, Erkrath

44106

GSK Investigational Site, Cleveland

44791

GSK Investigational Site, Bochum

47533

GSK Investigational Site, Kleve-Materborn

47574

GSK Investigational Site, Goch

72712

GSK Investigational Site, Bentonville

77090

GSK Investigational Site, Houston

86720

GSK Investigational Site, Nördlingen

92868

GSK Investigational Site, Orange

7580206

GSK Investigational Site, Santiago

01801

GSK Investigational Site, Woburn

C1425BEA

GSK Investigational Site, Ciudad Autonoma de Buenos Aires

Unknown

GSK Investigational Site, Ciudad Autonoma de Buenos Aires

GSK Investigational Site, San José

2403 JK

GSK Investigational Site, Alphen aan den Rijn

7581 BV

GSK Investigational Site, Losser

2371 RB

GSK Investigational Site, Roelofarendsveen

3011 TD

GSK Investigational Site, Rotterdam

6027 RN

GSK Investigational Site, Soerendonk

3443 GG

GSK Investigational Site, Woerden